Mei-Hsin Su1, Ying-Hsiu Shih2, Yen-Feng Lin3, Pei-Chun Chen2, Chia-Yen Chen4,5, Po-Chang Hsiao6, Yi-Jiun Pan7, Yu-Li Liu3, Shih-Jen Tsai8, Po-Hsiu Kuo6, Chi-Shin Wu9, Yen-Tsung Huang10, Shi-Heng Wang11,12. 1. Department of Occupational Safety and Health, College of Public Health, China Medical University, Taichung, Taiwan. 2. Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan. 3. Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan. 4. Biogen, Cambridge, MA, USA. 5. Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. 6. College of Public Health, National Taiwan University, Taipei, Taiwan. 7. School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan. 8. Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan. 9. Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan. 10. Institute of Statistical Science, Academia Sinica, Taipei, Taiwan. 11. Department of Occupational Safety and Health, College of Public Health, China Medical University, Taichung, Taiwan. wangsh@mail.cmu.edu.tw. 12. Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan. wangsh@mail.cmu.edu.tw.
Abstract
AIMS/HYPOTHESIS: Psychiatric disorders, such as schizophrenia (SCZ), major depressive disorder (MDD) and bipolar disorder (BPD), are highly comorbid with type 2 diabetes. However, the mechanisms underlying such comorbidity are understudied. This study explored the familial aggregation of common psychiatric disorders and type 2 diabetes by testing family history association, and investigated the shared genetic loading between them by testing the polygenic risk score (PRS) association. METHODS: A total of 105,184 participants were recruited from the Taiwan Biobank, and genome-wide genotyping data were available for 95,238 participants. The Psychiatric Genomics Consortium-derived PRS for SCZ, MDD and BPD was calculated. Logistic regression was used to estimate the OR with CIs between a family history of SCZ/MDD/BPD and a family history of type 2 diabetes, and between the PRS and the risk of type 2 diabetes. RESULTS: A family history of type 2 diabetes was associated with a family history of SCZ (OR 1.23, 95% CI 1.08, 1.40), MDD (OR 1.19, 95% CI 1.13, 1.26) and BPD (OR 1.26, 95% CI 1.15, 1.39). Compared with paternal type 2 diabetes, maternal type 2 diabetes was associated with a higher risk of a family history of SCZ. SCZ PRS was negatively associated with type 2 diabetes in women (OR 0.92, 95% CI 0.88, 0.97), but not in men; the effect of SCZ PRS reduced after adjusting for BMI. MDD PRS was positively associated with type 2 diabetes (OR 1.04, 95% CI 1.00, 1.07); the effect of MDD PRS reduced after adjusting for BMI or smoking. BPD PRS was not associated with type 2 diabetes. CONCLUSIONS/ INTERPRETATION: The comorbidity of type 2 diabetes with psychiatric disorders may be explained by shared familial factors. The shared polygenic loading between MDD and type 2 diabetes implies not only pleiotropy but also a shared genetic aetiology for the mechanism behind the comorbidity. The negative correlation between polygenic loading for SCZ and type 2 diabetes implies the role of environmental factors.
AIMS/HYPOTHESIS: Psychiatric disorders, such as schizophrenia (SCZ), major depressive disorder (MDD) and bipolar disorder (BPD), are highly comorbid with type 2 diabetes. However, the mechanisms underlying such comorbidity are understudied. This study explored the familial aggregation of common psychiatric disorders and type 2 diabetes by testing family history association, and investigated the shared genetic loading between them by testing the polygenic risk score (PRS) association. METHODS: A total of 105,184 participants were recruited from the Taiwan Biobank, and genome-wide genotyping data were available for 95,238 participants. The Psychiatric Genomics Consortium-derived PRS for SCZ, MDD and BPD was calculated. Logistic regression was used to estimate the OR with CIs between a family history of SCZ/MDD/BPD and a family history of type 2 diabetes, and between the PRS and the risk of type 2 diabetes. RESULTS: A family history of type 2 diabetes was associated with a family history of SCZ (OR 1.23, 95% CI 1.08, 1.40), MDD (OR 1.19, 95% CI 1.13, 1.26) and BPD (OR 1.26, 95% CI 1.15, 1.39). Compared with paternal type 2 diabetes, maternal type 2 diabetes was associated with a higher risk of a family history of SCZ. SCZ PRS was negatively associated with type 2 diabetes in women (OR 0.92, 95% CI 0.88, 0.97), but not in men; the effect of SCZ PRS reduced after adjusting for BMI. MDD PRS was positively associated with type 2 diabetes (OR 1.04, 95% CI 1.00, 1.07); the effect of MDD PRS reduced after adjusting for BMI or smoking. BPD PRS was not associated with type 2 diabetes. CONCLUSIONS/ INTERPRETATION: The comorbidity of type 2 diabetes with psychiatric disorders may be explained by shared familial factors. The shared polygenic loading between MDD and type 2 diabetes implies not only pleiotropy but also a shared genetic aetiology for the mechanism behind the comorbidity. The negative correlation between polygenic loading for SCZ and type 2 diabetes implies the role of environmental factors.
Authors: Suraj Sarvode Mothi; Neeraj Tandon; Jaya Padmanabhan; Ian T Mathew; Brett Clementz; Carol Tamminga; Godfrey Pearlson; John Sweeney; Matcheri S Keshavan Journal: Schizophr Res Date: 2015-04-19 Impact factor: 4.939
Authors: Kadri Haljas; Azmeraw T Amare; Behrooz Z Alizadeh; Yi-Hsiang Hsu; Thomas Mosley; Anne Newman; Joanne Murabito; Henning Tiemeier; Toshiko Tanaka; Cornelia van Duijn; Jingzhong Ding; David J Llewellyn; David A Bennett; Antonio Terracciano; Lenore Launer; Karl-Heinz Ladwig; Marylin C Cornelis; Alexander Teumer; Hans Grabe; Sharon L R Kardia; Erin B Ware; Jennifer A Smith; Harold Snieder; Johan G Eriksson; Leif Groop; Katri Räikkönen; Jari Lahti Journal: Psychosom Med Date: 2018-04 Impact factor: 4.312
Authors: S J Winham; A B Cuellar-Barboza; A Oliveros; S L McElroy; S Crow; C Colby; D-S Choi; M Chauhan; M Frye; J M Biernacka Journal: Mol Psychiatry Date: 2013-12-10 Impact factor: 15.992
Authors: Jaya L Padmanabhan; Pranav Nanda; Neeraj Tandon; Suraj S Mothi; Nicolas Bolo; Steven McCarroll; Brett A Clementz; Elliot S Gershon; Godfrey D Pearlson; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan Journal: J Psychiatr Res Date: 2016-02-23 Impact factor: 4.791
Authors: J Das-Munshi; M Ashworth; M E Dewey; F Gaughran; S Hull; C Morgan; J Nazroo; I Petersen; P Schofield; R Stewart; G Thornicroft; M J Prince Journal: Diabet Med Date: 2017-01-30 Impact factor: 4.359
Authors: Toni-Kim Clarke; Jana Obsteter; Lynsey S Hall; Caroline Hayward; Pippa A Thomson; Blair H Smith; Sandosh Padmanabhan; Lynne J Hocking; Ian J Deary; David J Porteous; Andrew M McIntosh Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2016-08-02 Impact factor: 3.568
Authors: C Kan; N L Pedersen; K Christensen; S R Bornstein; J Licinio; J H MacCabe; K Ismail; F Rijsdijk Journal: Mol Psychiatry Date: 2016-03-29 Impact factor: 15.992